Dolenio for osteoarthritis

Dolenio is a new glucosamine product licensed for the symptomatic treatment of mild to moderate osteoarthritis of the knee.

Dolenio is a once daily tablet formulation of glucosamine sulphate.

Treatment may take several weeks or longer to provide relief of symptoms; if after 2 to 3 months no symptom relief is observed then continued treatment with glucosamine should be reviewed.

View Dolenio drug record

Further information: Blue Bio Pharmaceuticals

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases